Drilling Down Into Cigna Corporation (CI)

Cigna Corporation (CI) is an interesting player in the Healthcare space, with a focus on Health Care Plans. The stock has been active on the tape, currently trading at $164.39, down from yesterday’s close by -1.75%. Given the stock’s recent action, it seemed like a good time to take a closer look at the company’s recent data.

Fundamental Analysis

Cigna Corporation (CI) currently trades with a market capitalization of $40.21 Billion. That value represents a market adjusting for revenues that have been growing by 5.98 % on a quarterly year/year basis as of the company’s last quarterly report.

You can get a sense of how sustainable that is by a levered free cash flow of $4.03 Billion over the past twelve months. Generally speaking, earnings are expected to grow in coming quarters. Analysts are forecasting earnings of $3.41 on a per share basis this quarter. Perhaps, that suggests something about why 1.56% of the outstanding share supply is held by institutional investors.

Technical Analysis

No analysis is ever complete without a thorough survey of a stock’s technical behavior. Looking at the stock’s movement on the chart, Cigna Corporation recorded a 52-week high of $227.13. It is now trading 62.74% off that level. The stock is trading $201.15 its 50-day moving average by 36.76%. The stock carved out a 52-week low down at $143.85.

In recent action, Cigna Corporation (CI) has made a move of -15.07% over the past month, which has come on Strong relative transaction volume. Over the trailing year, the stock is underperforming the S&P 500 by 16.68, and it’s gotten there by action that has been less volatile on a day-to-day basis than most other stocks on the exchange. In terms of the mechanics underlying that movement, traders will want to note that the stock is trading on a float of 1.07% with $240.17 Million sitting short, betting on future declines. That suggests something of the likelihood of a short squeeze in shares of CI.

Previous articleMondelez International, Inc. (MDLZ): From Top to Bottom
Next articleThe Case for and Against CVS Health Corporation (CVS)